Cultivating a Three-dimensional Reconstructed Human Epidermis at a Large Scale.


Journal

Journal of visualized experiments : JoVE
ISSN: 1940-087X
Titre abrégé: J Vis Exp
Pays: United States
ID NLM: 101313252

Informations de publication

Date de publication:
28 05 2021
Historique:
entrez: 14 6 2021
pubmed: 15 6 2021
medline: 8 10 2021
Statut: epublish

Résumé

A three-dimensional human epidermis model reconstructed from neonatal primary keratinocytes is presented. Herein, a protocol for the cultivation process and the characterization of the model is described. Neonatal primary keratinocytes are grown submerged on permeable polycarbonate inserts and lifted to the air-liquid interface three days after seeding. After fourteen days of stimulation with defined growth factors and ascorbic acid in high calcium culture medium, the model is fully differentiated. Histological analysis revealed a completely stratified epidermis, mimicking the morphology of native human skin. To characterize the model and its barrier functions, protein levels and localization specific for early-stage keratinocyte differentiation (i.e., keratin 10), late-stage differentiation (i.e., involucrin, loricrin, and filaggrin) and tissue adhesion (i.e., desmoglein 1), were assessed by immunofluorescence. The tissue barrier integrity was further evaluated by measuring transepithelial electrical resistance. Reconstructed human epidermis was responsive to proinflammatory stimuli (i.e., lipopolysaccharide and tumor necrosis factor alpha), leading to increased cytokine release (i.e., interleukin 1 alpha and interleukin 8). This protocol represents a straightforward and reproducible in vitro method to cultivate reconstructed human epidermis as a tool to assess environmental effects and a broad range of skin-related studies.

Identifiants

pubmed: 34125092
doi: 10.3791/61802
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Irini M Dijkhoff (IM)

Adolphe Merkle Institute, University of Fribourg.

Benedetta Petracca (B)

Adolphe Merkle Institute, University of Fribourg; Dow Silicones Belgium SRL.

Roxane Prieux (R)

Department of Biomedical and Specialist Surgical Sciences, University of Ferrara.

Giuseppe Valacchi (G)

Department of Biomedical and Specialist Surgical Sciences, University of Ferrara; Department of Animal Sciences, Plants for Human Health Institute, North Carolina State University.

Barbara Rothen-Rutishauser (B)

Adolphe Merkle Institute, University of Fribourg.

Marc Eeman (M)

Dow Silicones Belgium SRL; marc.eeman@dow.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH